Related Experiment Video
Updated: May 14, 2026
04:21
A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
Published on: August 4, 2021
[Pediatrics. New treatment options for viral bronchiolitis]
1Unité de pneumologie pédiatrique, DMCP, Département medico-chirurgical de pédiatrie, CHUV, 1011 Lausanne. isabelle.rochat@chuv.ch
Revue Medicale Suisse
|February 16, 2013
Summary
New treatments like nebulized epinephrine and high-dose dexamethasone show promise for infant viral bronchiolitis. Further research is necessary to confirm their effectiveness and guide general recommendations for this common respiratory illness.
Area of Science:
- Pediatrics
- Respiratory Medicine
- Infectious Diseases
Context:
- Viral bronchiolitis is a common respiratory infection in infants.
- Current treatment options for bronchiolitis are limited.
- New therapeutic strategies are being explored to improve infant outcomes.
Purpose:
- To evaluate the efficacy of novel therapeutic strategies for viral bronchiolitis.
- To assess the potential of nebulized epinephrine and high-dose dexamethasone.
- To investigate the role of nebulized hypertonic saline in managing infant bronchiolitis.
Summary:
- Nebulized epinephrine combined with high-dose dexamethasone presents a promising approach for treating viral bronchiolitis.
- Nebulized hypertonic saline is also emerging as a potential therapeutic option.
- These strategies require further investigation before widespread clinical adoption.
Impact:
- These findings could lead to improved treatment protocols for viral bronchiolitis.
- Enhanced therapeutic options may reduce hospitalization rates and symptom severity in infants.
- Further research will clarify the optimal use of these interventions in pediatric respiratory care.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: